Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2023-02-24 Investor Presentation
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a detailed presentation made to investors and analysts during a scheduled call on 24th February 2023. It includes extensive company information, market data, financial highlights for Q4 2022 and YTD Dec 2022, business strategy, and ESG initiatives. The text explicitly mentions it is a presentation made during an Investor / Analysts Call and that the transcript and recording will be uploaded later. The content is consistent with an Investor Presentation (IP) rather than a transcript or a brief earnings release. It is not a full annual or interim report, nor an announcement of voting results or regulatory filing. Therefore, the most appropriate classification is Investor Presentation (IP).
2023-02-24 English
Please find enclosed herewith the presentation made to the Investors / Analysts Call and the same is also being uploaded on the website of the Company. The recording and transcript of the ....
Investor Presentation Classification · 95% confidence The document is a detailed presentation made to investors and analysts during a call held on 24th February 2023. It includes extensive information about the company's business, market position, financial highlights for Q4 2022 and YTD Dec 2022, growth strategies, and ESG initiatives. The text explicitly mentions that this is a presentation made during an Investor / Analysts Call and that the transcript and recording will be uploaded later. The content is typical of an Investor Presentation, focusing on financials, strategy, and market position rather than being a formal earnings release or annual report. It is not a transcript of the call itself, nor is it a brief earnings release or regulatory filing. Therefore, the most appropriate classification is Investor Presentation (IP). The document length (13,599 characters) supports that this is a full presentation rather than a short announcement or report publication notice.
2023-02-24 English
We would like to inform you that the Board of Directors at its meeting held today i.e., Thursday, 23rd February 2023, considered and approved convening of the 67th AGM of the Company on ....
Notice of Dividend Amount Classification · 95% confidence The document is a letter dated 23rd February 2023 from the Company Secretary of Sanofi India Limited addressed to stock exchanges. It announces the outcome of a Board Meeting, specifically regarding the recommendation of a final dividend and a second special dividend for the financial year ended 31st December 2022, the total dividend amount, the date of the Annual General Meeting (AGM), and the book closure dates. The document does not contain detailed financial statements or comprehensive financial analysis but rather communicates decisions made by the Board related to dividends and AGM scheduling. It is an announcement of dividend amounts and AGM details, not the dividend notice itself or the full AGM materials. Therefore, the document fits best under the category of Notice of Dividend Amount (DIV), as it primarily announces dividend amounts and related payment details.
2023-02-23 English
Dividend
Notice of Dividend Amount Classification · 95% confidence The document is a letter dated 23rd February 2023 from the company secretary to stock exchanges announcing the outcome of a board meeting. It details the recommendation of a final dividend and a second special dividend for the financial year ended 31st December 2022, the total dividend amount, the approval to convene the 67th Annual General Meeting (AGM), and the book closure dates for dividend payment. The document does not contain financial statements or detailed financial analysis but is an official announcement of dividend amounts, AGM date, and book closure dates. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and related shareholder information. The document length is short (2626 characters), and it is not a report itself but an announcement of dividend and AGM details. Therefore, the correct classification is DIV with high confidence.
2023-02-23 English
Resolved to close the Register of Members of the Company from Saturday, 29th April 2023 to Thursday, 11th May, 2023 (both days inclusive) for the purpose of payment of final and second ....
Notice of Dividend Amount Classification · 95% confidence The document is a letter dated 23rd February 2023 from the company secretary to stock exchanges announcing the outcome of a board meeting. It details the recommendation of a final dividend and a second special dividend for the financial year ended 31st December 2022, the total dividend amount, the date of the upcoming 67th Annual General Meeting (AGM), and the book closure dates for dividend payment. The document does not contain financial statements or detailed financial data but is an announcement of dividend decisions and AGM scheduling. It is relatively short (2626 characters) and serves as an official notification to the stock exchanges rather than a full report. Therefore, it fits the category of Notice of Dividend Amount (DIV) as it announces dividend amounts, payment dates, and related shareholder information.
2023-02-23 English
Book Closure
Notice of Dividend Amount Classification · 95% confidence The document is a letter dated 23rd February 2023 from the company secretary to stock exchanges announcing the outcome of a Board Meeting. It details the recommendation of a final dividend and a second special dividend for the financial year ended 31st December 2022, subject to shareholder approval at the upcoming 67th Annual General Meeting (AGM). It also announces the AGM date and book closure dates. The document is short (2626 characters) and primarily serves as an announcement of dividend amounts and meeting dates rather than a full report or detailed financial statements. It does not contain financial statements or detailed analysis but rather official information about dividend declaration and AGM scheduling. Therefore, it fits the category of Notice of Dividend Amount (DIV) as it announces dividend amounts, payment dates, and related shareholder information.
2023-02-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.